Stay updated on Nivolumab in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab in Untreated Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2 release.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check52 days agoChange DetectedThe page displays a government funding notice about potential delays and the NIH Clinical Center's status. The revision history shows an update from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check59 days agoChange DetectedUI text updates include Show glossary and Hide glossary options, along with minor capitalization tweaks in labels (e.g., Met QC Criteria vs met QC Criteria and Data vs data). The revision note shows the version bump from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check73 days agoChange DetectedNew revision label added: Revision: v3.3.4 replaces v3.3.3, representing a minor UI update that does not affect the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.